Hypofractionated, palliative radiotherapy for advanced head and neck cancer
- 31 October 2008
- journal article
- Published by Elsevier BV in Radiotherapy and Oncology
- Vol. 89 (1), 51-56
- https://doi.org/10.1016/j.radonc.2008.06.007
Abstract
No abstract availableThis publication has 22 references indexed in Scilit:
- The ‘QUAD SHOT’—a phase II study of palliative radiotherapy for incurable head and neck cancerRadiotherapy and Oncology, 2005
- Radiotherapy with or without mitomycin c in the treatment of locally advanced head and neck cancer: results of the IAEA multicentre randomised trialRadiotherapy and Oncology, 2003
- International consensus on palliative radiotherapy endpoints for future clinical trials in bone metastasesRadiotherapy and Oncology, 2002
- Radiotherapy for brain metastases: defining palliative responseRadiotherapy and Oncology, 2001
- Continuous hyperfractionated accelerated radiotherapy with/without mitomycin C in head and neck cancersRadiotherapy and Oncology, 2000
- A comparison of radiotherapy or radiochemotherapy with symptomatic treatment alone in patients with advanced head and neck carcinomas.European Archives of Oto-Rhino-Laryngology, 2000
- Palliative care in patients with cancer of the head and neckClinical Otolaryngology, 1997
- Randomized phase
I II trial of two variants of accelerated fractionated radiotherapy regimens for advanced head and neck cancer: Results of RTOG 88-09International Journal of Radiation Oncology*Biology*Physics, 1995 - Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European organization for research and treatment of cancer (EORTC)International Journal of Radiation Oncology*Biology*Physics, 1995
- Treatment of Patients with Stage IV Cancer: Do the Ends Justify the Means?Otolaryngology -- Head and Neck Surgery, 1987